Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of the Sensitivity of Inhomogeneous Magnetization Transfer (ihMT) MRI for Multiple Sclerosis.

AJNR. American journal of neuroradiology·2018

Same author

Shaping and preserving β-cell identity with microRNAs.

Diabetes, obesity & metabolism·2016

Same author

MicroRNAs in pancreas development.

Diabetes, obesity & metabolism·2012

Same author

Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E.

Diabetologia·2011

Same author

Oleate-mediated activation of phospholipase D and mammalian target of rapamycin (mTOR) regulates proliferation and rapamycin sensitivity of hepatocarcinoma cells.

Diabetologia·2011

Same author

The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion.

Diabetologia·2010

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

SOCS proteins causing trouble in insulin action.

P Lebrun¹, E Van Obberghen

¹Inserm, U145, Faculté de Médecine, Institut de Génétique et Signalisation Moléculaire (IFR50), Université de Nice-Sophia Antipolis, et Laboratoire de Biochimie, CHU, Nice, France.

Acta Physiologica (Oxford, England)

|January 4, 2008

Summary

This summary is machine-generated.

Suppressor of cytokine signalling (SOCS) proteins inhibit insulin signalling through multiple mechanisms. Increased SOCS-3 expression correlates with insulin resistance and type 2 diabetes.

More Related Videos

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

Related Experiment Videos

Last Updated: Jul 8, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

Area of Science:

Biochemistry
Molecular Biology
Endocrinology

Background:

Suppressor of cytokine signalling (SOCS) proteins are induced regulators of various signalling pathways.
SOCS proteins, particularly SOCS-1 and SOCS-3, are known inhibitors of cytokine signalling.
Recent research highlights their role in repressing pathways, including insulin signalling.

Purpose of the Study:

To investigate the mechanisms by which SOCS proteins inhibit insulin signalling.
To explore the correlation between SOCS protein expression and insulin resistance.
To understand the role of SOCS proteins in the context of type 2 diabetes.

Main Methods:

In vitro and in vivo studies examining the interaction of SOCS-1 and SOCS-3 with the insulin signalling pathway.
Analysis of insulin receptor substrate (IRS) protein phosphorylation and degradation.
Assessment of insulin receptor (IR) kinase activity.
Correlation studies of SOCS-3 expression levels in patients and animal models with insulin resistance and type 2 diabetes.

Main Results:

SOCS-1 and SOCS-3 inhibit insulin signalling via three primary mechanisms: inhibiting IRS protein tyrosine phosphorylation, inducing IRS proteasomal degradation, and inhibiting IR kinase activity.
SOCS protein expression is typically low in basal conditions but rapidly induced by stimuli.
A significant positive correlation was observed between SOCS-3 expression and insulin resistance in vivo.

Conclusions:

SOCS proteins, especially SOCS-3, play a significant role in inhibiting insulin signalling.
Elevated SOCS-3 expression is notably enhanced in tissues affected by type 2 diabetes and insulin resistance.
While causality is under investigation, SOCS proteins are implicated in the pathophysiology of insulin resistance.